Unicorn Nest Logo

Yanchuang Capital

www.yccapital.cn
Total investments

19

Average round size

33M

Portfolio companies

16

Rounds per year

1.36

Lead investments

3

Follow on index

0.16

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareHealth Care3D TechnologyManufacturingMedicalLife SciencePharmaceuticalTherapeuticsLivestock

Investments analytics

Analytics

Total investments
19
Lead investments
3
Rounds per year
1.36
Follow on index
0.16
Investments by industry
  • Biotechnology (9)
  • Health Care (5)
  • Pharmaceutical (4)
  • Medical (4)
  • Therapeutics (3)
    • Show 19 more
Investments by region
  • China (14)
  • United States (2)
Peak activity year
2021

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.
Sign Up

Quantitative data

Avg. startup age at the time of investment
7
Group Appearance index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Upgrade

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Avistone Pharmaceuticals 28 Dec 2023 Biotechnology Early Stage Venture 154M Beijing, Beijing, China
Carma 31 Dec 2018 Transportation, Software, Information Technology, Car Sharing, Ride Sharing, Sharing Economy Early Stage Venture United States, Texas, Austin
EpimAb Biotherapeutics 22 Mar 2021 Biotechnology, Health Care, Therapeutics, Biopharma Late Stage Venture 120M Shanghai, China

Similar funds

By same location

Gaorong Capital Venture Capital
DST Global Venture Capital
Cowin Capital Venture Capital
SBCVC Venture Capital
Lilly Asia Ventures Venture Capital

By same geo focus

CICC Bank

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.